Health advocacy organizations reluctant to acknowledge grant money from drug companies, study finds

A study by the American Journal of Public Health shows not-for-profit groups like the American Diabetes Association get grant money from drug companies but don't necessarily acknowledge it.

Marian Wang of ProPublica, the nonprofit investigative news service, highlighted the results of the study, which examined 160-plus health advocacy organizations that got funding in 2007 from Eli Lilly & Co., a global pharmaceutical company.

The report found that, as a whole, "25 percent of health advocacy organizations acknowledged Lilly funding anywhere on their Web site. Eighteen percent acknowledged Lilly in their 2007 annual report, 1 percent acknowledged Lilly on a corporate sponsors page, and 10 percent acknowledged Lilly as the sponsor" of a grant event reported in the Lilly Grant Registry. (Read more)